AstraZeneca could relocate its vaccine manufacturing from the UK to the US after negotiations with the Labour government over reducing state aid reached an impasse. Britain’s finance minister proposes cutting state provisions. Still, AstraZeneca is committed to its Liverpool project and is in positive discussions with the UK government to support this planned investment.